Thea D' Ambrosio

Array ( [id] => 10954817 [patent_doc_number] => 20140357838 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-04 [patent_title] => 'N-Terminally Modified Insulin Derivatives' [patent_app_type] => utility [patent_app_number] => 14/366987 [patent_app_country] => US [patent_app_date] => 2012-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40975 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14366987 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9792753 [patent_doc_number] => 20150004697 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-01 [patent_title] => 'METHOD FOR PRODUCING MULTIPOLAR CELL' [patent_app_type] => utility [patent_app_number] => 14/366971 [patent_app_country] => US [patent_app_date] => 2012-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7788 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14366971 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10960858 [patent_doc_number] => 20140363889 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-11 [patent_title] => 'METHOD FOR PRODUCING MULTIPOLAR CELL' [patent_app_type] => utility [patent_app_number] => 14/367023 [patent_app_country] => US [patent_app_date] => 2012-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7421 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14367023 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9874707 [patent_doc_number] => 08961971 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-02-24 [patent_title] => 'Bispecific T-cell activator antibody' [patent_app_type] => utility [patent_app_number] => 13/720573 [patent_app_country] => US [patent_app_date] => 2012-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 4846 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 169 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13720573 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9657295 [patent_doc_number] => 20140228301 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-14 [patent_title] => 'RECOMBINANT HUMAN ALPHA-1-ANTITRYPSIN FOR THE TREATMENT OF INFLAMMATORY DISORDERS' [patent_app_type] => utility [patent_app_number] => 14/342170 [patent_app_country] => US [patent_app_date] => 2012-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 9887 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14342170 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10297592 [patent_doc_number] => 20150182591 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-07-02 [patent_title] => 'METHOD OF TREATING HYPERGLYCEMIC DISORDERS USING APOLIPOPROTEIN AIV' [patent_app_type] => utility [patent_app_number] => 14/416541 [patent_app_country] => US [patent_app_date] => 2012-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 10577 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14416541 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9799525 [patent_doc_number] => 20150011469 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-08 [patent_title] => 'METHOD OF TREATING DIABETES USING NON-GLYCOSYLATED APOLIPOPROTEIN A-IV' [patent_app_type] => utility [patent_app_number] => 14/373259 [patent_app_country] => US [patent_app_date] => 2012-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 13712 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14373259 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11750412 [patent_doc_number] => 09708414 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-07-18 [patent_title] => 'Methods and products for increasing frataxin levels and uses thereof' [patent_app_type] => utility [patent_app_number] => 14/358156 [patent_app_country] => US [patent_app_date] => 2012-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 67 [patent_figures_cnt] => 74 [patent_no_of_words] => 15805 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 210 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14358156 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9813072 [patent_doc_number] => 20150025016 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-22 [patent_title] => 'PEPTIDES THAT INHIBIT THE INTERACTION BETWEEN ASF1 AND HISTONES, AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 14/358875 [patent_app_country] => US [patent_app_date] => 2012-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11467 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14358875 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10109201 [patent_doc_number] => 09144593 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-09-29 [patent_title] => 'Pharmaceutical composition for preventing or treating Th17-mediated disease comprising poly-gamma-glutamic acid' [patent_app_type] => utility [patent_app_number] => 13/678225 [patent_app_country] => US [patent_app_date] => 2012-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 19 [patent_no_of_words] => 11038 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13678225 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9806332 [patent_doc_number] => 20150018278 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-15 [patent_title] => 'PHOSPHORYLATION ON THE THR-248 AND/OR THR-250 RESIDUES OF TRANSCRIPTION FACTOR E2F4 AS A THERAPEUTIC TARGET IN PATHOLOGICAL PROCESSES ASSOCIATED WITH SOMATIC POLYPLOIDY' [patent_app_type] => utility [patent_app_number] => 14/352584 [patent_app_country] => US [patent_app_date] => 2012-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4812 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14352584 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10234348 [patent_doc_number] => 20150119343 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-04-30 [patent_title] => 'Production of TSG-6 Protein' [patent_app_type] => utility [patent_app_number] => 14/354381 [patent_app_country] => US [patent_app_date] => 2012-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9014 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14354381 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9686490 [patent_doc_number] => 20140243255 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-28 [patent_title] => 'TREATMENTS FOR MYCOBACTERIUM TUBERCULOSIS' [patent_app_type] => utility [patent_app_number] => 14/352440 [patent_app_country] => US [patent_app_date] => 2012-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 37745 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14352440 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9720951 [patent_doc_number] => 20140256653 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-11 [patent_title] => 'WHEY PROTEIN MICELLES TO ENHANCE MUSCLE MASS AND PERFORMANCE' [patent_app_type] => utility [patent_app_number] => 14/351092 [patent_app_country] => US [patent_app_date] => 2012-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3111 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14351092 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8768031 [patent_doc_number] => 20130096068 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-18 [patent_title] => 'COMBINATION THERAPY WITH A PROTEASOME INHIBITOR AND A GALLIUM COMPLEX' [patent_app_type] => utility [patent_app_number] => 13/655475 [patent_app_country] => US [patent_app_date] => 2012-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3235 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13655475 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9699393 [patent_doc_number] => 20140249078 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-04 [patent_title] => 'WHEY PROTEIN MICELLES AGAINST MUSCLE ATROPHY AND SARCOPENIA' [patent_app_type] => utility [patent_app_number] => 14/353177 [patent_app_country] => US [patent_app_date] => 2012-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3416 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14353177 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16369072 [patent_doc_number] => 10800813 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-10-13 [patent_title] => Modulation of structured polypeptide specificity [patent_app_type] => utility [patent_app_number] => 14/350192 [patent_app_country] => US [patent_app_date] => 2012-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 17 [patent_no_of_words] => 24160 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 136 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14350192 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9699607 [patent_doc_number] => 20140249292 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-04 [patent_title] => 'MODULATION OF STRUCTURED POLYPEPTIDE SPECIFICITY' [patent_app_type] => utility [patent_app_number] => 14/350263 [patent_app_country] => US [patent_app_date] => 2012-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 18525 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14350263 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8683870 [patent_doc_number] => 20130052154 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-28 [patent_title] => 'Compositions and Methods for the Treatment of Lung Inflammation' [patent_app_type] => utility [patent_app_number] => 13/646029 [patent_app_country] => US [patent_app_date] => 2012-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 15375 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13646029 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9772482 [patent_doc_number] => 20140296146 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-02 [patent_title] => 'Thermostable Inhibitors of Activation of the Blood Clotting System Through Contact with Foreign Surfaces' [patent_app_type] => utility [patent_app_number] => 14/240292 [patent_app_country] => US [patent_app_date] => 2012-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 15726 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14240292 [rel_patent_id] =>[rel_patent_doc_number] =>)